(Q73244325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

fluticasone propionate

1 reference

Pearlman DS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Noonan MJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Tashkin DP

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Goldstein MF

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hamedani AG

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kellerman DJ

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Schaberg A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

356-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

A new approach to the treatment of asthma

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963196-1

7 January 2021

10.1016/S1081-1206(10)63196-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9109702%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference